A study to assess the effect of fluvoxamine and smoking on pharmacokinetics ( the movement of drugs within the body) of AZD4635 in healthy volunteers

Trial Identifier:	D8730C00007
Sponsor:	AstraZeneca
Collaborator:	Parexel International
NCTID::	NCT04478513
Start Date:	July 2020
Primary Completion Date:	December 2020
Study Completion Date:	December 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.